Literature DB >> 8609401

Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein.

J Wang1, E Nemoto, G Dennert.   

Abstract

Receptor-mediated activation of T lymphocytes involves protein phosphorylation by several protein tyrosine kinases, among those the src-related enzymes p56lck and p59fyn. Accumulating evidence supports the notion that these enzymes are regulated by tyrosine phosphorylation and dephosphorylation, but much is yet to be learned about regulation of their activity. Here we demonstrate that p56lck but not p59fyn exists as a complex with a 40-kDa protein, which in its ADP-ribosylated form inhibits p56lck kinase activity. ADP-ribosylation of this protein is mediated by an arginine-specific mono-ADP-ribosyltransferase, which makes use of extracellular nicotinamide adenine dinucleotide (NAD). This enzyme is a glycosyl-phosphatidylinositol-anchored protein releasable from the surface of cytotoxic T cells by glycosyl-phosphatidylinositol-specific phospholipase C. Release of arginine-specific mono-ADP-ribosyltransferase results in failure of extracellular NAD to downmodulate p56lck kinase activity. Concomitant to suppression of the kinase by NAD, CD8 mediated transmembrane signaling and p56lck kinase activation are inhibited.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.

Authors:  Xiangning Bu; Jiro Kato; Joel Moss
Journal:  Biochem Pharmacol       Date:  2018-09-27       Impact factor: 5.858

2.  Identification of a novel pathway of transforming growth factor-β1 regulation by extracellular NAD+ in mouse macrophages: in vitro and in silico studies.

Authors:  Ruben Zamora; Nabil Azhar; Rajaie Namas; Mallikarjuna R Metukuri; Thierry Clermont; Chase Gladstone; Rami A Namas; Linda Hermus; Cristina Megas; Gregory Constantine; Timothy R Billiar; Mitchell P Fink; Yoram Vodovotz
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

Review 3.  Characterization of NAD:arginine ADP-ribosyltransferases.

Authors:  J Moss; E Balducci; E Cavanaugh; H J Kim; P Konczalik; E A Lesma; I J Okazaki; M Park; M Shoemaker; L A Stevens; A Zolkiewska
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

4.  Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase.

Authors:  B A Saxty; M Yadollahi-Farsani; P D Upton; S R Johnstone; J MacDermot
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.

Authors:  Wiebke Ohlrogge; Friedrich Haag; Jürgen Löhler; Michel Seman; Dan R Littman; Nigel Killeen; Friedrich Koch-Nolte
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis.

Authors:  Jiro Kato; Jianfeng Zhu; Chengyu Liu; Mario Stylianou; Victoria Hoffmann; Martin J Lizak; Connie G Glasgow; Joel Moss
Journal:  Cancer Res       Date:  2011-06-22       Impact factor: 12.701

7.  Molecular characterization and expression of the gene for mouse NAD+:arginine ecto-mono(ADP-ribosyl)transferase, Art1.

Authors:  R Braren; G Glowacki; M Nissen; F Haag; F Koch-Nolte
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

8.  Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia.

Authors:  Björn Rissiek; Stephan Menzel; Mario Leutert; Maike Cordes; Sarah Behr; Larissa Jank; Peter Ludewig; Mathias Gelderblom; Anne Rissiek; Sahil Adriouch; Friedrich Haag; Michael O Hottiger; Friedrich Koch-Nolte; Tim Magnus
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

9.  Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.

Authors:  Lian Yang; Ming Xiao; Xian Li; Yi Tang; Ya-Lan Wang
Journal:  Int J Mol Med       Date:  2016-01-29       Impact factor: 4.101

10.  Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.

Authors:  Masanori Noguchi; Noriko Koga; Fukuko Moriya; Shigetaka Suekane; Shigeru Yutani; Akira Yamada; Shigeki Shichijo; Tatuyuki Kakuma; Kyogo Itoh
Journal:  Cancer Sci       Date:  2018-07-23       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.